Form 8-K - Current report:
SEC Accession No. 0001193125-24-246551
Filing Date
2024-10-29
Accepted
2024-10-29 16:16:34
Documents
14
Period of Report
2024-10-29
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d902376d8k.htm   iXBRL 8-K 25458
2 EX-10.1 d902376dex101.htm EX-10.1 1253026
  Complete submission text file 0001193125-24-246551.txt   1682068

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA ndoi-20241029.xsd EX-101.SCH 2500
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE ndoi-20241029_lab.xml EX-101.LAB 15167
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ndoi-20241029_pre.xml EX-101.PRE 9513
16 EXTRACTED XBRL INSTANCE DOCUMENT d902376d8k_htm.xml XML 3198
Mailing Address 1400 ATWATER DRIVE MALVERN PA 19355
Business Address 1400 ATWATER DRIVE MALVERN PA 19355 (484) 216-0000
Endo, Inc. (Filer) CIK: 0002008861 (see all company filings)

EIN.: 301390281 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 333-280767 | Film No.: 241405931
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)